Fig. 1: LncRNA CERS6-AS1 is high expression in HCC tissues and cell lines. | Cell Death Discovery

Fig. 1: LncRNA CERS6-AS1 is high expression in HCC tissues and cell lines.

From: Long noncoding RNA CERS6-AS1 modulates glucose metabolism and tumor progression in hepatocellular carcinoma by promoting the MDM2/p53 signaling pathway

Fig. 1

A The expression levels of CERS6-AS1 between tumors and normal tissues based on GEPIA database. B, C The expression levels of CERS6-AS1 among different tumor Grade or Stage based on TCGA database. (Normal group is the control group). D, E Cox regression analysis based on TCGA database was performed to evaluate whether CERS6-AS1 is an independent risk factor of HCC prognosis, involving in age, gender, grade and stage. F, G Kaplan–Meier survival results of overall survival and disease-free survival based on CERS6-AS1 levels in HCC samples. H The expression of CERS6-AS1 in 38 paired HCC tissues and normal tissues. I CERS6-AS1 expression in HCC cell lines, LO2 cell line is the control group. J Kaplan–Meier survival results of overall survival based on CERS6-AS1 expression in HCC patients. (high CERS6-AS1 expression group, n = 19; low CERS6-AS1 expression group, n = 19). K FISH assay was performed to detect the location of CERS6-AS1. Scale bar: 50 μm. L Relative CERS6-AS1 expression in nucleus and cytoplasm. All experiments included were repeated at least three times, *p < 0.05, **p < 0.01.

Back to article page